NO972127L - Metode for redusering av strengheten av gastro-intestinal skade - Google Patents

Metode for redusering av strengheten av gastro-intestinal skade

Info

Publication number
NO972127L
NO972127L NO972127A NO972127A NO972127L NO 972127 L NO972127 L NO 972127L NO 972127 A NO972127 A NO 972127A NO 972127 A NO972127 A NO 972127A NO 972127 L NO972127 L NO 972127L
Authority
NO
Norway
Prior art keywords
severity
reducing
gastrointestinal injury
damage
individual
Prior art date
Application number
NO972127A
Other languages
English (en)
Norwegian (no)
Other versions
NO972127D0 (no
Inventor
Beverly E Girten
Paul Omholt
Ronald R Tuttle
Original Assignee
Houghten Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Houghten Pharm Inc filed Critical Houghten Pharm Inc
Publication of NO972127D0 publication Critical patent/NO972127D0/no
Publication of NO972127L publication Critical patent/NO972127L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
NO972127A 1995-09-12 1997-05-07 Metode for redusering av strengheten av gastro-intestinal skade NO972127L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/527,252 US5888978A (en) 1995-09-12 1995-09-12 Method for reducing the severity of gastro-intestinal damage
PCT/US1996/014744 WO1997009995A1 (en) 1995-09-12 1996-09-12 Method for reducing the severity of gastro-intestinal damage

Publications (2)

Publication Number Publication Date
NO972127D0 NO972127D0 (no) 1997-05-07
NO972127L true NO972127L (no) 1997-06-27

Family

ID=24100728

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972127A NO972127L (no) 1995-09-12 1997-05-07 Metode for redusering av strengheten av gastro-intestinal skade

Country Status (8)

Country Link
US (1) US5888978A (de)
EP (1) EP0790831A1 (de)
JP (1) JPH10509985A (de)
KR (1) KR970706835A (de)
AU (1) AU715001B2 (de)
CA (1) CA2205056A1 (de)
NO (1) NO972127L (de)
WO (1) WO1997009995A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236766B2 (en) 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
US7842662B2 (en) 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
WO2008057608A2 (en) 2006-11-10 2008-05-15 Cara Therapeutics, Inc. Synthetic peptide amides
US8906859B2 (en) 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
US7713937B2 (en) 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
WO2024095040A1 (en) 2022-11-02 2024-05-10 Levchenko Vladimir Viktorovich Method for improving colour characteristics and/or transparency of at least one natural corundum and in particular a ruby

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420109A (en) * 1993-11-12 1995-05-30 Houghten Pharmaceuticals, Inc. Cytokine restraining agents

Also Published As

Publication number Publication date
AU6977796A (en) 1997-04-01
AU715001B2 (en) 2000-01-13
US5888978A (en) 1999-03-30
CA2205056A1 (en) 1997-03-20
NO972127D0 (no) 1997-05-07
EP0790831A1 (de) 1997-08-27
KR970706835A (ko) 1997-12-01
WO1997009995A1 (en) 1997-03-20
JPH10509985A (ja) 1998-09-29

Similar Documents

Publication Publication Date Title
NO990405L (no) Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
WO1995033464A3 (en) Retroviral protease inhibitor combinations
AR053946A2 (es) Variante de alfa-amilasa de bacillus stearothermophilus original
NO942994L (no) Aminoacetylmercaptoacetylamidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
ATE222761T1 (de) Tetrahydrofuranyl (thf) enthaltende sulfonamidinhibitoren der aspartyl-protease
TR199701544T1 (xx) Yeni dolastatin t�revleri,bunlar�n haz�rlanmas� ve kullan�lmas�.
EP1048659A4 (de) Retinoid-rezeptor-antagonisten
DK163304C (da) Glutarimidderivat, fremgangsmaade til dets fremstilling og dets anvendelse som angstdaempende og antihypertensivt middel
NO965516L (no) Sterolderivater anvendt til regulering av meiose
DK1143955T3 (da) En kombination af FBPase-inhibitorer og insulinsensibiliseringsmidler til behandling af diabetes
NO995928L (no) Alfa-1-antitrypsin-preparater samt fremgangsmåte ved fremstilling derav
NO973551D0 (no) Indoler med brostruktur som matriksmetallproteaseinhibitorer
AU2066297A (en) Method and apparatus for performing an operation multiple times in response o a single instruction
NO982874L (no) Farmasöytiske preparater med vitamin D-analoger
NO911956D0 (no) Oxydant sensitive og insensitive aromatiske estere som inhibitorer for human neutrofilelastase.
NO972127L (no) Metode for redusering av strengheten av gastro-intestinal skade
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
ATE186514T1 (de) Packung
NO982229L (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som anti-inflammatoriske midler
AU1711692A (en) Method for regulating enzyme activities by noble gases
DE69625099D1 (de) Vorrichtung für einen Ringkammerofen
DK0869785T3 (da) 4-Hydroxycoumarin-3-carboxyamider til behandling af ikke-insulinafhængig diabetes mellitus
DK0613323T3 (da) Piezokeramisk kapsel til telefoninstrumenter
NO962015D0 (no) Pyron-derivater som protease-inhibitorer og antivirus-midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application